← Open Payments lookup

ROBERT BACON: Open Payments

NPI 1700951704 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,112 in 73 payments from 14 companies in 2025. Trend: 2023 $911 · 2024 $1,387 · 2025 $2,112

Food & beverage: $2,112
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$538
Teva Pharmaceuticals USA, Inc.10$377
Neurocrine BioSciences, Inc.13$313
Alkermes, Inc.8$289
Otsuka America Pharmaceutical, Inc.8$179
E.R. Squibb & Sons, L.L.C.7$170
Bausch Health US, LLC3$68
ABBVIE INC.3$62
Vanda Pharmaceuticals Inc.1$25
Lundbeck LLC1$22

Products named: CAPLYTA, INGREZZA, UZEDY, ARISTADA, COBENFY, AUSTEDO XR, LYBALVI, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.